A group of scientists reported that they have pieced together the back story of a gene known as CD33 that could lead to exciting new ways of removing the amyloid plaques that build up in the brains of Alzheimer’s patients and cause so many problems with memory and cognitive functions. Rudolph Tanzi, the Joseph P. and Rose F. Kennedy Professor of Neurology at Massachusetts General Hospital, led the study.
